ShortageWatch RxUS drug shortage tracker, built on FDA data

← All shortages

Prazosin Hydrochloride Capsule shortage

To Be Discontinued  3 presentations · 1 manufacturers · first FDA posting 2023-04-28 · last update 2023-04-28

Manufacturers: Pfizer Inc.

Stated reasons (per FDA): Not stated

📬 Get weekly shortage updates by email

Presentations

PresentationManufacturerStatusReasonNotes (FDA)Dates
Minipress, Capsule, 1 mg (NDC 0069-4310-71)Pfizer Inc.To Be Discontinued
 —Discontinuation of the manufacture of the drug. Supply expected to exhaust in August 2023Posted 04/28/2023
Updated 04/28/2023
Discontinued 04/28/2023
Minipress, Capsule, 2 mg (NDC 0069-4370-71)Pfizer Inc.To Be Discontinued
 —Discontinuation of the manufacture of the drug. Supply expected to exhaust in September 2023Posted 04/28/2023
Updated 04/28/2023
Discontinued 04/28/2023
Minipress, Capsule, 5 mg (NDC 0069-4380-71)Pfizer Inc.To Be Discontinued
 —Discontinuation of the manufacture of the drug. Supply expected to exhaust in September 2023Posted 04/28/2023
Updated 04/28/2023
Discontinued 04/28/2023

Source: FDA Drug Shortages Database · raw openFDA records

Get the weekly shortage roundup: a free email of FDA shortage changes (open form)